RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy.

Oncotarget · 2017 · PMC5351588 · PMID 28052017

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For all 8 loci, T samples displayed highly significant hypermethylation compared to NM samples (Figure 3 ) with AUCs ranging from 0.79 ( HLF ) to 0.91 ( LINC01341 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.